Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.46
+0.17 (2.33%)
Oct 6, 2025, 11:28 AM EDT - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $242.61 million as of October 6, 2025. Its market cap has increased by 124.91% in one year.
Market Cap
242.61M
Enterprise Value
101.77M
1-Year Change
124.91%
Ranking
Category
Stock Price
$7.46
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $242.61M, a decrease of -31.62%. That is a compound annual growth rate of -15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 237.08M | 63.64% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |